您当前的位置：
首页 >
文章列表页 >
Progress and outlook of fundamental and translational breast cancer research in China, 2025
更新时间：2026-04-08

    • Progress and outlook of fundamental and translational breast cancer research in China, 2025

    • Chin Oncol   Vol. 36, Issue 2, Pages: 95-101(2026)

    • DOI：10.19401/j.cnki.1007-3639.2026.02.001    

      CLC： R737.9

    • Received：26 January 2026，

      Revised：2026-02-07，

      Published：28 February 2026

    移动端阅览

  • CHE X X, XIE Y F, WANG H, et al. Progress and outlook of fundamental and translational breast cancer research in China, 2025［J］. Chin Oncol, 2026, 36(2): 95-101. DOI： 10.19401/j.cnki.1007-3639.2026.02.001.

  •  
  •  

0

Views

62

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Significant fundamental translational research on breast cancer in China in 2025
Application progress of single-cell sequencing technology in breast cancer research
Single-cell RNA sequencing and its application in breast cancer
Scheduling of chemotherapy based on direct monitoring of pO2 in tumor microenvironment by EPR oximetry
2025 research hotspots and prospects of endocrine therapy for HR+/HER2- breast cancer

Related Author

Che Xiangxian
Xie Yifan
Wang Han
Jiang Yi-Zhou
Qiang LIU
Yi FANG
Jing WANG
韩香臣

Related Institution

Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
复旦大学附属肿瘤医院乳腺外科，复旦大学上海医学院肿瘤学系
重庆医科大学附属第一医院内分泌乳腺外科
大连医科大学附属第二医院乳腺肿瘤科
大连医科大学
0